Concepedia

Shri Niwas

SN

Statistics

Publications

9

Citations

399

H-Index

9

Active since

1983

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

Southern Research Institute

Shri Niwas is an author at BioCryst Pharmaceuticals (United States) specializing in enzyme inhibition, purine chemistry, and purine analogues.

Publications per year

1983–2000

9

Publications

9

Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(Arylmethyl) derivatives of 9-deazaguanine

John A. Montgomery, Shri Niwas, Jerry D. Rose et al. · Journal of Medicinal Chemistry · 1993 · 132 citations · Full text

, , +15

Structure-based design of inhibitors of purine nucleoside phosphorylase. 3. 9-Arylmethyl derivatives of 9-deazaguanine substituted on the arylmethyl group

Mark D. Erion, Shri Niwas, Jerry D. Rose et al. · Journal of Medicinal Chemistry · 1993 · 64 citations · Full text

, , +11

The Arthus Reaction in Rodents: Species-Specific Requirement of Complement

Alexander J. Szalai, Stanley B. Digerness, Alok Agrawal et al. · The Journal of Immunology · 2000 · 57 citations

, , +17

Structure-based design of inhibitors of purine nucleoside phosphorylase. 2. 9-Alicyclic and 9-heteroalicyclic derivatives of 9-deazaguanine

J. A. III SECRIST, Shri Niwas, Jerry D. Rose et al. · Journal of Medicinal Chemistry · 1993 · 48 citations · Full text

, , +17

Structure-Based Design of Inhibitors of Purine Nucleoside Phosphorylase. 5. 9-Deazahypoxanthines

Shri Niwas, Pooran Chand, Ved P. Pathak et al. · Journal of Medicinal Chemistry · 1994 · 29 citations · Full text

, , +15

1–5 of 9